Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 04:09:59 +0200Tue, 28 May 2024 15:33:00 +0200Opinion/decision on a Paediatric investigation plan (PIP): Odefsey, emtricitabine,rilpivirine,tenofovir alafenamide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0193/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001679-pip01-14-m03Opinion/decision on a Paediatric investigation plan (PIP): Odefsey, emtricitabine,rilpivirine,tenofovir alafenamide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0193/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001679-pip01-14-m03Tue, 28 May 2024 15:33:00 +0200Human medicine